Clinical Trial Update: A Study of BB-1701 in Previously Treated Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive or HER2-low Unresectable or Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for BB-1701 in previously treated HER2-positive or HER2-low unresectable/metastatic breast cancer shows the study is active but …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• BB-1701

Snippet

Sponsor: Eisai Inc. | Conditions: Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING